Min Fang

Min Fang currently works at HTDK Medical Holdings Ltd., as Chairman from 2021, Warburg Pincus Asia LLC (China Rep.
Office), as Managing Director, Warburg Pincus Investment Consulting Co. Ltd., as Managing Director from 2016, EA, Inc., as Director, Beijing Huamei Fude Medical Technology Co., Ltd., as Executive Director & Manager, InSilico Medicine Hong Kong Ltd., as Director, Shanghai Haihe Biopharma Co., Ltd., as Director from 2020, Sichuan Jinxin Fertility Medical Management Co., Ltd., as Director, and Beijing Warburg Pincus Investment Consulting Co. Ltd., as Principal from 2011.
Mr. Fang also formerly worked at China Biologic Products, Inc., as Director from 2015 to 2016, PW Medtech Group Ltd., as Non-Executive Director in 2015, Beijing Amcare Women's & Children's Hospital Co., Ltd., as Director, China Biologic Products Holdings, Inc., as Director from 2015 to 2016, Beijing Amcare Medical Management Co., Ltd., as Director, Hygeia Healthcare Holdings Co., Ltd., as Non-Executive Director in 2021, and Jinxin Fertility Group Ltd., as Non-Executive Director from 2018 to 2025.
Mr. Fang received his undergraduate degree from Fudan University and Masters Business Admin degree in 2007 from Stanford Graduate School of Business.